Eddy Lee

About Eddy Lee

Drug development and manufacturing leader with >30 years of experience in the pharmaceutical industry at Mirati, Turning Point, Biosplice, Clearside Biomedical, Aviragen, Blend and Genzyme. Highly skilled in moving late-stage assets through manufacturing validation preparing for launch and commercialization. Experience in problem solving and fixing validation challenges. Well-versed with US & global regulatory filings, agency interactions, PAI readiness and quality systems. Deep expertise in the art of process development throughout the drug development life cycle, providing strategic insight & guidance to senior management. Successfully planned global manufacturing strategies for clinical and commercial materials with attention to quality, cost, and efficiency. Led the relationship with contract manufacturers world-wide, assured production needs were met in compliance with current cGMP and developed secure, high quality supply chains. Proven leadership skills and experience building highly productive teams, which strive for excellence and that innovate. Knowledgeable in acquisitions, due diligence, and successful transitioning of assets. Developed global supply chain networks with attention to minimizing geopolitical risks. Skilled in bringing the core elements of technical operations together & creating a unified team. Experienced in developing multiple drug product modalities. SVP at Mirati responsible for Tech Ops including Krazati commercial & clinical operations and a robust portfolio of early assets. SVP at Turning Point Therapeutics managing all aspects of Augtyro manufacturing culminating in a successful launch. VP CMC at Biosplice Therapeutics managing all aspects of development across the portfolio including Lorecivivint (OA). VP of CMC at Clearside Biomedical responsible for managing all aspects of manufacturing for Xipere, preparing for NDA & launch. VP of CMC at Aviragen responsible for API and drug product manufacture. VP and Head of Manufacturing at Blend Therapeutics and responsible for building the synthetic capabilities from the ground up. VP of Chemical Process Development at Genzyme with demonstrated expertise and leadership in process development, manufacturing, CMC, and project management. Recognized as a leader, motivator, and achiever. Built an organization, kilo-laboratory, and infrastructure to scale up chemical entities from research through to commercial. Developed cost effective and scalable processes for key programs. Excellent record of introducing innovative technologies & versed in multiple disease areas.

Experience

1. SVP Technical Operations

   Structure Therapeutics

   Jun 2025 — Present · South San Francisco, CA, US

Education

• University of Bern

  Post-doctoral study, Organic Chemistry

  1988 — 1989

• University of Warwick

  Doctor of Philosophy (PhD), Organic Chemistry

  1985 — 1988

• University of Warwick

  Bachelor of Science (BS), Chemistry

  1982 — 1985

Skills

• Biotechnology
• Mentoring
• Pharmaceutical Industry
• Drug Development
• Clinical Trials
• Organic Chemistry
• Outsourcing
• Chemistry
• Analytical Chemistry
• Product Development
• Entrepreneurship
• Chemical Engineering
• Polymers
• Clinical Development